6. Technological developments for new applications
6.1 Therapeutic proteins and antibodies
The annual market for therapeutic biomolecules is worth over 145 billion dollars. Recombinant monoclonal antibodies are by far the most representative class of therapeutic biomolecules on this market. In the vast majority of cases, they are produced in CHO cells. Despite their ability to produce perfectly assembled and functional monoclonal antibodies
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Technological developments for new applications
Conclusion
Bibliography
- (1) - ABE (T.), MATSUURA (Y.) - Host innate immune responses induced by baculovirus in mammals. - Curr. Gene. Ther., 10, p. 226-231 (2010).
- (2) - AIRENNE (K.J.), HU (Y.C.), KOST (T.A.), SMITH (R.H.), KOTIN (R.M.), ONO (C.), MATSUURA (Y.), WANG (S.), YLÄ-HERTTUALA (S.) - Baculovirus : an insect-derived...
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Article included in this offer
"Drugs and pharmaceuticals"
(
131 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
